Pegge NC, Twomey AM, Vaughton K, et al. Time dependant changes of erectile function in diabetic rats: role of systemic endothelial dysfunction. Diabet Med 2006; 23: 873–878.
4.
Shores MM, Matsumoto AM, Sloan KL, et al. Low serum testosterone and mortality in male veterans. Arch Int Med 2006; 166: 1660–1665.
5.
CourtenayWH. Constructions of masculinity and their influence on men’s well-being: a theory of gender and health. Social Sci Med2000; 50: 1385–1401.
6.
Charmaz K. Identity dilemmas of chronically ill men. In Sabo D and Gordon DF (eds) Men’s health and illness: gender, power and the body. Thousand Oaks, LA: Sage, 1995, pp. 266–291.
Edwards D, Hood C and Collins O. Attitudes towards erectile dysfunction (ED) and its treatment. J Sex Med 2008; 5(suppl2): 45–68.
9.
EdwardsD. Using a COSH to encourage compliance when treating patients for erectile dysfunction. J Men’s Health2010; 7: 326–326.
10.
JacksonG. The importance of risk factor reduction in ED. Curr Urol Rep2007; 8: 463–466.
11.
Mulhall J, King R, Glina S, et al. Importance of and satisfaction with sex among men and women worldwide: results of the global better sex survey. J Sex Med 2008; 5788–5795.
12.
EdwardsDHackettGCollinsO. Vardenafil improves sexual function and treatment satisfaction in couples affected by erectile dysfunction (ED): a randomised, double blind, placebo controlled trial in PDE5 inhibitor naïve men with ED and their partners. J Sex Med2006; 3: 1028–1036.
13.
AlthofSEEidJFTulleyS. Through the eyes of women: the partner’s perspective on tadalafil. Urology2006, pp. 68631–68635.
